Source: Eur Respir J, 54 (3) 1901394; 10.1183/13993003.01394-2019
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Giovanni Sotgiu, Delia Goletti, Alberto Matteelli. Global tuberculosis prevention: should we start from the beginning?. Eur Respir J, 54 (3) 1901394; 10.1183/13993003.01394-2019

Member's Comments

No comment yet.

Related content which might interest you: Is it necessary to give tuberculosis treatment daily throughout? Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 The new era of diagnostics: will it ever start? Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship Year: 2019 Tobacco and tuberculosis: could we improve tuberculosis outcomes by helping patients to stop smoking? Source: Eur Respir J 2015; 45: 583-585 Year: 2015 Tuberculosis: considerations on the period between disease beginning and diagnosis moment Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001 Tuberculosis diagnostics: which target product profiles should be prioritised? Source: Eur Respir J 2014; 44: 537-540 Year: 2014 COVID-19 epidemiology and prevention: Global update Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Global TB control: facts and challenges Source: Annual Congress 2008 - New insights into tuberculosis control Year: 2008 Tuberculosis elimination: where are we now? Source: Eur Respir Rev, 27 (148) 180035; 10.1183/16000617.0035-2018 Year: 2018 Awareness and Pneumonia knowledge: where to start educating? Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified? Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 From Bench to edside: Development of a drug to treat lung disease from a basic research start Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value? Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 New-entrant screening for tuberculosis at port of entry in the U.K.: Is it time to change policy? Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 Rapid monitoring of tuberculosis treatment response: A multi-centre study Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment Year: 2016 Do we need to screen for latent TB when initiating a methotrexate treatment? Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013